Is a complete MED research report available?

No complete published report is available for Medifast, Inc. (MED) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Medifast, Inc. (MED)

NYSE: MED · USD

$9.68

+0.23 (+2.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MED analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	99.3M
Revenue (ttm)	346.1M
Net income (ttm)	-20M
EPS (ttm)	-$1.82
Shares out	10.3M
Volume	207,488
Beta	0.68

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 346.1M
Net income (ttm): -20M
EPS (ttm): -$1.82
Market cap: 99.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABNB	Airbnb Inc.	90.8B	37.5x	7.2x	15.9%	+29.9%	+7.6%	Hold
AMZN	Amazon.com Inc.	2.4T	27.1x	3.3x	13.5%	+12.1%	-2.6%	Reduce
BKNG	Booking Holdings Inc.	156B	26.2x	5.6x	75.0%	+37.4%	-10.6%	Buy

All MED indicators

Market & fundamental data

Available fields

220

Groups with data

Currency

USD

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000910329
Company name	Medifast, Inc.
Country	United States
Country code	US
Cusip	58470H101
Employees	380
Employees Change	-124%
Employees Change Percent	-24.6
Enterprise value	$-53.6M
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Personal Services
Industry PE	21.5
Industry PE Fwd	18.41
Isin	US58470H1014
Last refreshed	2026-07-25
Market cap	$99.3M
Market cap category	Micro-Cap
Price	$9.68
Price currency	USD
Rev Per Employee	910,800x
Sector	Consumer Discretionary
Sector PE	35.25
Sector PE Fwd	24.09
Sic	2090
Symbol	MED
Website	https://medifastinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-20.17%
FCF yield	-1.48%
P/B ratio	0.5x
P/S ratio	0.29x
PE Ratio10 Y	37.22x
PE Ratio3 Y	84.35x
PE Ratio5 Y	50.57x
PS Forward	0.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-4.69%
EBITDA Margin	-0.52%
Gross margin	70.12%
Gross Profit	$242.7M
Gross Profit Growth	-39.56%
Gross Profit Growth Q	-38.56%
Gross Profit Growth3 Y	-39.51%
Gross Profit Growth5 Y	-21.44%
Net Income	$-20M
Net Income Growth Years	0%
Pretax Margin	-2.34%
Profit Margin	-5.78%
Profit Per Employee	$-52,689
ROA	-4.33
Roa5y	19.51
ROCE	-7.74
ROE	-9.8
Roe5y	43.83
ROIC	-42.28
Roic5y	101.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-9.54%
Cagr15y	-3.33%
Cagr1y	-36.38%
Cagr20y	-1.74%
Cagr3y	-52.77%
Cagr5y	-47.84%
Div CAGR3	13.39%
Div CAGR5	27.97%
EPS Growth Years	0
OCF Growth	-81.96%
OCF Growth Q	-92.37%
OCF Growth10 Y	-17.98%
OCF Growth3 Y	-74.14%
OCF Growth5 Y	-54.17%
Revenue Growth	-36.31x
Revenue Growth Q	-34.29x
Revenue Growth Years	0x
Revenue Growth3 Y	-39.07x
Revenue Growth5 Y	-20.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.3
Assets	$252M
Cash	$168.9M
Current Assets	$202.6M
Current Liabilities	$42.2M
Debt	$16.1M
Debt Equity	$0.08
Equity	$197.7M
Liabilities	$54.4M
Long Term Assets	$49.4M
Long Term Liabilities	$12.2M
Net Cash	$152.8M
Net Cash By Market Cap	$154
Net Cash Growth	1.91%
Net Debt Equity	$-0.77
Tangible Book Value	$197.7M
Tangible Book Value Per Share	$19.28
WACC	6.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.8
Inventory Turnover	3.4
Net Working Capital	$-4.6M
Quick ratio	4
Working Capital	$160.4M
Working Capital Turnover	$2.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.51%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$1.65

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-63.29%
1Y total return	-36.36%
200-day SMA	11.31
3Y total return	-89.47%
50-day SMA	11.44
50-day SMA vs 200-day SMA	50over200
5Y total return	-96.14%
All Time High	337
All Time High Change	-97.13%
All Time High Date	2021-05-28
All Time Low	0.09
All Time Low Change	10,219.83%
All Time Low Date	1999-12-23
ATR	0.42
Beta	0.68
Beta1y	1.3
Beta2y	0.84
Ch YTD	-9.36
High	9.7
High52	15.31
High52 Date	2025-07-24
High52ch	-36.77%
Low	9.39
Low52	9.22
Low52 Date	2026-03-13
Low52ch	4.99%
Ma50ch	-15.4%
Price vs 200-day SMA	-14.42%
RSI	33.41
RSI Monthly	27.11
RSI Weekly	37.43
Sharpe ratio	-1.01x
Sortino ratio	-1.42
Total Return	-0.51%
Tr YTD	-9.36
Tr15y	-39.82%
Tr1m	-8.85%
Tr1w	-5.65%
Tr3m	-11.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.66
Earnings Revenue Estimate	73,830,000x
Earnings Revenue Estimate Growth	-30.09x
Operating Income	$-18.4M
Operating margin	-5.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,755,372%
Float Percent	75.64%
Shares Insiders	3.9%
Shares Institutions	69.77%
Shares Out	10,253,115
Shares Qo Q	0.14%
Shares Yo Y	0.51%
Short Float	20.14%
Short Ratio	5.68
Short Shares	15.23

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-9.1M
Average Volume	250,572.1x
Bv Per Share	19.28
CAPEX	$-5.2M
Ch10y	-71.51
Ch15y	-54.45
Ch1m	-8.85
Ch1w	-5.65
Ch1y	-36.36
Ch20y	-46.7
Ch3m	-11.84
Ch3y	-89.68
Ch5y	-96.56
Ch6m	-19.67
Change	2.43%
Change From Open	2.54
Close	9.45
Days Gap	-0.11
Depreciation Amortization	14,445,000
Dollar Volume	2,008,483.8
Earnings Date	2026-08-03
Earnings Time	amc
EBIT	$-16.2M
EBITDA	$-1.8M
EPS	$-1.82
F Score	3
FCF	$-1.5M
FCF EV Yield	2.74x
FCF Per Share	$-0.14
Financing CF	-902,000
Fiscal Year End	December
Founded	1,980
Income Tax	$11.9M
Investing CF	-23,007,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-17
Ma150	11.1
Ma150ch	-12.75%
Ma20	10.53
Ma20ch	-8.08%
Net CF	-20,188,000
Next Earnings Date	2026-08-03
Open	9.44
Optionable	Yes
P OCF Ratio	26.7
Position In Range	93.55
Ppne	42,564,000
Price Date	2026-07-24
Ptbv Ratio	0.5
Relative Volume	0.83x
Revenue	346,104,000x
SBC By Revenue	2.2x
Share Based Comp	7,605,000
Tax By Revenue	3.44x
Tr20y	-29.58%
Tr6m	-19.67%
Us State	Maryland
Volume	207,488
Z Score	4.19

Medifast, Inc. (MED)

Coverage state: Market snapshot only — no published research

Generate the first MED analysis

Price

Financial snapshot

Fair-value bridge

Latest news · MED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MED indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on MED

Frequently asked questions